CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ÇãÁö¿µ
  • ±âÁõÁ¦´ëÇ÷ÀºÇàÀå
    Áø´Ü°Ë»çÀÇÇаúÀå
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : Áø´ÜÇ÷¾×ÇÐ, ¼öÇ÷ÀÇÇÐ, Á¶Á÷ÀûÇÕ¼º, ºÐÀÚÀ¯Àü
  • Á÷ À§: ±³¼ö(±âÁõÁ¦´ëÇ÷ÀºÇàÀå,Áø´Ü°Ë»çÀÇÇаúÀå)
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­:
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
90 (±¹¿Ü)SCIE Clonality and Resistome Analysis of KPC-Producing Klebsiella pneumoniae Strain Isolated in Korea Using Whole Genome Sequencing
89 (±¹³»)±âŸ ±¹³» ÁßȯÀÚ½Ç È¯ÀÚ¿¡¼­ ºÐ¸®µÈ ¼¼±ÕÀÇ Ç×±ÕÁ¦ ³»¼º
88 (±¹¿Ü)SCI Estimation of size of cord blood inventory based on high-resolution typing of HLAs.
87 (±¹¿Ü)SCI First Outbreak of KPC-2-Producing Klebsiella pneumoniae Sequence Type 258 in a Hospital in South Korea
86 (±¹¿Ü)SCIE Novel nonsense GNAS mutation in a 14-month-old boy with plate-like osteoma cutis and medulloblastoma
85 (±¹³»)KCIÈĺ¸ Assessment of Cell Viability in Umbilical Cord Blood by Using 7-AAD/annexin V Dual Staining
84 (±¹¿Ü)SCI HLA-A, -B and -DRB1 polymorphism in Koreans defined by sequence-based typing of 4128 cord blood units
83 (±¹¿Ü)SCIE Allogenic umbilical cord blood therapy combined with erythropoietin for patients with severe traumatic brain injury: Three case reports
82 (±¹³»)KCI Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea
81 (±¹³»)KCI Characterization of anti-factor VIII antibody in a patient with acquired hemophilia A
ÀÌÀüÆäÀÌÁö À̵¿ 1 2 3 4 5 6 7 8 9 10 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729